RecruitingRecruiting
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
NCT06528418 · ChromX Health
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
About this study
This is a prospective, cross-sectional, observational cohort study aimed at recruiting 10,000 participants with multiple pulmonary disease, including lung cancer, lung infection, chronic obstructive pulmonary disease (COPD), bronchitis, pulmonary fibrosis, pulmonary embolism, pulmonary arterial hypertension, tuberculosis, lung abscess, emphysema, radioactive lung injury, cystic fibrosis of the lung, Bronchial Asthma, Bronchiectasis, interstitial lung disease (ILD), preserved ratio impaired spirometry (PRISm) etc . Exhaled breath samples from these participants will be collected and analyzed using Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system. Upon obtaining the μGC-PID results, a comprehensive evaluation of the diagnostic capabilities of exhaled breath samples in differentiating various pulmonary diseases will be performed, leveraging clinical diagnostic results, CT examination data, and clinical data.
Eligibility criteria
Inclusion Criteria:
* Males or females, age must be 18 years old or above.
* Patients must meet the CT imaging diagnostic criteria for different lung diseases, and patients must be able to provide electronic versions of CT image data.
* Patients must have a clear clinical diagnosis.
* All participants must sign a written informed consent form.
Exclusion Criteria:
* Pregnant women.
* Individuals with a history of cancer other than lung disease.
* Individuals who have undergone organ transplants or non-autologous (allogeneic) bone marrow or stem cell transplants.
* Individuals with other severe organic diseases or mental illnesses.
* Individuals with metabolic diseases such as diabetes, hyperlipidemia, etc.
* Any other condition that researchers deem unsuitable for participation in this clinical trial.
Study design
Enrollment target: 10000 participants
Age groups: adult, older_adult
Timeline
Starts: 2024-06-30
Estimated completion: 2027-06-30
Last updated: 2025-03-26
Interventions
Other: Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system
Primary outcomes
- • The diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in the diagnosis of several common pulmonary diseases. (2 years)
Sponsor
ChromX Health · industry
With: The First Affiliated Hospital of Guangzhou Medical University, First People's Hospital of Foshan, Sichuan Cancer Hospital and Research Institute, Liwan District Central Hospital, Shanghai Chest Hospital, Peking Union Medical College Hospital, Guangzhou Development Zone Hospital, Huangpu District Hongshan Street Community Health Service Center, Huangpu District Chinese Medicine Hospital, Fifth Affiliated Hospital of Guangzhou Medical University, Huangpu District Jiufo Street Community Health Service Center, Huangpu District Xinlong Town Central Hospital, Huangpu District Yonghe Street Community Health Service Center, Huangpu District Lianhe Street Second Community Health Service Center
Contacts & investigators
ContactHengrui Liang, MD · contact · hengrui_liang@163.com · +86 15625064712
InvestigatorJianxing He, MD · study_chair, The First Affiliated Hospital of Guangzhou Medical University
All locations (1)
The First Affiliated Hospital of Guangzhou Medical UniversityRecruiting
Guangzhou, Guangdong, China